Quanyi S. Lu

Xiamen, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications

A Multicenter National Study of AL Amyloidosis in China: Insights Into Real-World Diagnosis, Treatment, and Prognosis.

A Multicenter National Study of AL Amyloidosis in China: Insights Into Real-World Diagnosis, Treatment, and Prognosis.

Journal: American journal of hematology
Published: March 23, 2026

Characteristics and Prognostic Implications in Newly Diagnosed KMT2Ar AML: A Multicenter Study of the ECLA Group.

Characteristics and Prognostic Implications in Newly Diagnosed KMT2Ar AML: A Multicenter Study of the ECLA Group.

Journal: American journal of hematology
Published: December 12, 2025

Homoharringtonine Promotes FTO Degradation to Suppress LILRB4-Mediated Immune Evasion in Acute Monocytic Leukaemia.

Homoharringtonine Promotes FTO Degradation to Suppress LILRB4-Mediated Immune Evasion in Acute Monocytic Leukaemia.

Journal: Cell proliferation
Published: April 04, 2025

PQQ Inhibits PRC2 Methyltransferase Activity and Suppresses the Proliferation of B-Cell Lymphoma In Vitro.

PQQ Inhibits PRC2 Methyltransferase Activity and Suppresses the Proliferation of B-Cell Lymphoma In Vitro.

Journal: Chemistry & biodiversity
Published: January 16, 2025

Genetically predicted the causal association between serum mineral elements with immune thrombocytopenia and Henoch-Schonlein purpura: a bidirectional two-sample Mendelian randomization analysis.

Genetically predicted the causal association between serum mineral elements with immune thrombocytopenia and Henoch-Schonlein purpura: a bidirectional two-sample Mendelian randomization analysis.

Journal: Thrombosis journal
Published: December 26, 2024

Transfusion burden and willingness to pay for temporary alleviation of anemia status in transfusion-dependent beta-thalassemia patients in China.

Transfusion burden and willingness to pay for temporary alleviation of anemia status in transfusion-dependent beta-thalassemia patients in China.

Journal: BMC health services research
Published: June 18, 2024

Co-existence of AML1-ETO and BCR-ABL1 fusion genes in acute myeloid leukemia: a case report

Co-existence of AML1-ETO and BCR-ABL1 fusion genes in acute myeloid leukemia: a case report

Journal: Zhonghua nei ke za zhi
Published: February 07, 2024

Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective study.

Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective study.

Journal: EJHaem
Published: January 20, 2024

Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial.

Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial.

Journal: Annals of hematology
Published: August 10, 2023

Tocilizumab combined with ruxolitinib in the treatment of children with steroid resistant graft versus host disease after hematopoietic stem cell transplantation: report of 6 cases.

Tocilizumab combined with ruxolitinib in the treatment of children with steroid resistant graft versus host disease after hematopoietic stem cell transplantation: report of 6 cases.

Journal: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
Published: May 18, 2023

Construction of a prognostic model of acute myeloid leukemia associated with immunogenic cell death.

Construction of a prognostic model of acute myeloid leukemia associated with immunogenic cell death.

Journal: Expert review of hematology
Published: April 28, 2023

Recombinant human thrombopoietin (rhTPO) of different dosing regimens for refractory/relapsed primary immune thrombocytopenia: a multicenter, randomized controlled trial and pharmacokinetics study.

Recombinant human thrombopoietin (rhTPO) of different dosing regimens for refractory/relapsed primary immune thrombocytopenia: a multicenter, randomized controlled trial and pharmacokinetics study.

Journal: Platelets
Published: January 03, 2023
Showing 1-12 of 42

Last Updated: 09/26/2026